Abstract
Objective
To compare radiomics and non-radiomics in predicting early recurrence (ER) in patients with hepatocellular carcinoma (HCC) after curative surgery.Methods
We systematically searched PubMed and Embase databases. Studies with clear reference criteria were selected. Data were extracted and assessed for quality using the quality in prognosis studies tool (QUIPS) by two independent authors. All included radiomics studies underwent radiomics quality score (RQS) assessment. We calculated sensitivity, specificity, positive likelihood ratio (PLR), and negative likelihood ratio (NLR) using random or fixed models with a 95%CI. Forest maps visualized the data, and summary receiver operating characteristic (sROC) curves with the area under the curve (AUC) were generated. Meta-regression and subgroup analyses explored sources of heterogeneity. We compared sensitivity, specificity, PLR, and NLR using the z-test and compared AUC values using the Delong test.Results
Our meta-analysis included 10 studies comprising 1857 patients. For radiomics, the pooled sensitivity, specificity, AUC of sROC, PLR and NLR were 0.84(95%CI: 0.78-0.89), 0.80(95%CI: 0.75-0.85), 0.89(95%CI: 0.86-0.91), 4.28(95%CI: 3.48-5.27) and 0.20(95%CI: 0.14-0.27), respectively, but with significant heterogeneity (I2 = 60.78% for sensitivity, I2 = 55.79% for specificity) and potential publication bias (P = 0.04). The pooled sensitivity, specificity, AUC of sROC, PLR, NLR for non-radiomics were 0.75(95%CI:0.68-0.81), 0.78(95%CI:0.72-0.83), 0.83(95%CI: 0.80-0.86), 3.45(95%CI: 2.68-4.44) and 0.32(95%CI: 0.24-0.41), respectively. There was no significant heterogeneity in this group (I2 = 0% for sensitivity, I2 = 17.27% for specificity). Radiomics showed higher diagnostic accuracy (AUC: 0.89 vs. 0.83, P = 0.0456), higher sensitivity (0.84 vs. 0.75, P = 0.0385) and lower NLR (0.20 vs. 0.32, P = 0.0287).Conclusion
The radiomics from preoperative MRI effectively predicts ER of HCC and has higher diagnostic accuracy than non-radiomics. Due to potential publication bias and suboptimal RQS scores in radiomics, these results should be interpreted cautiously.References
Articles referenced by this article (36)
Patterns of cancer recurrence in localized resected hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int, (3):269-275 2015
MED: 26063027
Predictors of early and late hepatocellular carcinoma recurrence.
World J Gastroenterol, (8):1243-1260 2023
MED: 36925456
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.
Hepatology, (2):723-750 2018
MED: 29624699
Guide for diagnosis and treatment of hepatocellular carcinoma.
World J Hepatol, (12):1632-1651 2015
MED: 26140083
Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Ann Oncol, (10):2105-2114 2018
MED: 30412221
Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection.
Med Phys, (2):778-790 2022
MED: 36269204
Radiomics for the detection of microvascular invasion in hepatocellular carcinoma.
World J Gastroenterol, (20):2176-2183 2022
MED: 35721882
Preoperative Diagnosis of Dual-Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models.
J Magn Reson Imaging, (4):1185-1196 2022
MED: 36190656
Predicting Microvascular Invasion in Hepatocellular Carcinoma Using CT-based Radiomics Model.
Radiology, (4):e222729 2023
MED: 37097141
Show 10 more references (10 of 36)
Citations & impact
Impact metrics
Article citations
Artificial intelligence in predicting recurrence after first-line treatment of liver cancer: a systematic review and meta-analysis.
BMC Med Imaging, 24(1):263, 07 Oct 2024
Cited by: 0 articles | PMID: 39375586 | PMCID: PMC11457388
Review Free full text in Europe PMC
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Radiomics as a tool for prognostic prediction in transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis.
Radiol Med, 129(8):1099-1117, 26 Jul 2024
Cited by: 0 articles | PMID: 39060885 | PMCID: PMC11322429
Review Free full text in Europe PMC
The Diagnostic Accuracy Between Radiomics Model and Non-radiomics Model for Preoperative of Microvascular Invasion of Solitary Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Acad Radiol, 31(11):4419-4433, 24 Apr 2024
Cited by: 0 articles | PMID: 38664142
Review
A Systematic Review and Meta-Analysis of MRI Radiomics for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma.
Curr Med Imaging, 20:1-11, 01 Jan 2024
Cited by: 0 articles | PMID: 38389371
Review
Prediction power of radiomics in early recurrence of hepatocellular carcinoma: A systematic review and meta-analysis.
Medicine (Baltimore), 103(27):e38721, 01 Jul 2024
Cited by: 0 articles | PMID: 38968499 | PMCID: PMC11224803
Review Free full text in Europe PMC